Skip to content

13F-HR filed by Lion Point Capital, LP

Lion Point Capital, LP filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 24 holding rows worth $455,916,000.

Accession
0001567619-20-019893
Filed
2020-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, 24 entries on the cover page, a total value of $455,916,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $455,916,000 with VALUE read as thousands by filing date, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CANADIAN SOLAR INC136635109COM3,327,426$116,792,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock1,558,472$45,943,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock1,327,734$35,530,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q200COM NEW2,718,334$34,930,000thousands by filing date
DURECT CORP266605104COM17,730,680$30,319,000thousands by filing date
LIBERTY GLOBAL PLCG5480U104SHS CL A1,250,000$26,262,000thousands by filing date
SIERRA WIRELESS INC826516106COM2,144,396$23,931,000thousands by filing date
ARCONIC ROLLED PRODS CORP03966V107COM1,168,749$22,264,000thousands by filing date
ALCOA CORP COM013872106Stock1,698,382$19,752,000thousands by filing date
PERSPECTA INC715347100COM900,000$17,505,000thousands by filing date
iShares Russell 2000 ETF464287655SHS93,000$13,930,000thousands by filing date
LATTICE SEMICONDUCTOR CORP COM518415104Stock458,188$13,269,000thousands by filing date
BATTALION OIL CORP07134L107COM1,435,981$11,344,000thousands by filing date
SPDR SER TR78468R556S&P OILGAS EXP237,500$9,992,000thousands by filing dateput
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A495,748$7,594,000thousands by filing date
LUMOS PHARMA INC55028X109COM407,192$5,627,000thousands by filing date
LOGICBIO THERAPEUTICS INC54142F102COM500,000$4,540,000thousands by filing date
OUTFRONT MEDIA INC69007J106COM300,000$4,365,000thousands by filing date
COMSCORE INC20564W105COM1,922,241$3,921,000thousands by filing date
EXTREME NETWORKS INC30226D106COM811,835$3,263,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM300,000$2,127,000thousands by filing date
OPES ACQUISITION CORP68373P209UNIT 03/07/202383,438$1,468,000thousands by filing date
OVINTIV INC69047Q102COM90,108$735,000thousands by filing date
LIBERTY GLOBAL PLCG5480U120SHS CL C25,000$513,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-20-019893this filing2020-11-16acceptance time not in the bulk data set